The OLFM1 (olfactomedin-1) antibody is a tool used to detect and study the OLFM1 protein, a member of the olfactomedin domain-containing protein family. OLFM1. also known as noelin or pancortin, is highly expressed in the nervous system and plays roles in neural development, including neurite outgrowth, synaptic plasticity, and cell adhesion. It interacts with extracellular matrix components and cell surface receptors, influencing signaling pathways critical for neuronal survival and differentiation.
OLFM1 antibodies are widely utilized in research to investigate its expression patterns and functional mechanisms. These antibodies enable techniques like Western blotting, immunohistochemistry, and immunofluorescence, helping to localize OLFM1 in tissues or cultured cells. Studies have linked OLFM1 dysregulation to neurological disorders (e.g., Alzheimer’s disease) and cancers (e.g., glioblastoma, colorectal cancer), where it may act as either a tumor suppressor or promoter depending on context.
The antibody’s specificity varies; some target conserved regions across species (human, mouse, rat), facilitating cross-species studies. Researchers also use OLFM1 antibodies to explore its interactions with binding partners like amyloid-beta or netrin-1. shedding light on disease pathways. Despite progress, OLFM1’s full biological significance remains under investigation, emphasizing the antibody’s ongoing role in elucidating its multifaceted functions.